Physician profile
Zia Rab
NPI 1548548332
$7,422.98
in general payments reported to CMS, 2019-2025
36 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,471 · 2020: $499 · 2021: $367 · 2022: $471 · 2023: $848 · 2024: $1,654 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,340 · Travel and Lodging: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,340.11 |
| Travel and Lodging | $274.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,289.12 | 2019-2024 | Esprit |
| Edwards Lifesciences Corporation | $1,015.69 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $814.49 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Varithena Administration Pack |
| Medtronic, INC. | $450.27 | 2021-2024 | Corevalve Evolut R, Resolute Onyx, Hawkone |
| E.R. Squibb & Sons, L.L.C. | $402.67 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $278.06 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.46 | 2019-2025 | Jardiance |
| Abiomed | $241.15 | 2020-2025 | |
| Baylis Medical Company INC | $149.18 | 2019 | |
| Philips North America LLC | $146.41 | 2020-2025 | IV Other, (Br5) Peripheral Ivus |
| Cardiovascular Systems INC. | $132.71 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $129.58 | 2022-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $126.19 | 2022-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $110.84 | 2020-2024 | Xarelto |
| Pfizer INC. | $110.63 | 2019-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $71.65 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $67.47 | 2019-2023 | Farxiga |
| Alnylam Pharmaceuticals INC. | $64.67 | 2022-2024 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $59.60 | 2021-2022 | |
| Surmodics, INC. | $59.35 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Shockwave Medical, INC | $58.74 | 2025 | |
| Medtronic Vascular, INC. | $55.31 | 2019-2020 | |
| Inari Medical, INC. | $53.17 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $37.77 | 2024-2025 | Rotarexs 6 F X 135 Cm |
| Tactile Systems Technology INC | $36.39 | 2025 | Flexitouch Plus, Nimbl |
| Inspiremd LTD | $31.30 | 2025 | Cguard Prime Carotid Stent System |
| Route 92 Medical, INC. | $26.68 | 2025 | |
| Terumo Medical Corporation | $24.26 | 2025 | Azur Cx Detachable |
| Sirtex Medical INC | $20.93 | 2025 | Lava Les (Liquid Embolic System) |
| Nevro Corp. | $17.82 | 2024 | Senza |
| Esperion Therapeutics, INC. | $16.82 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $15.68 | 2019 | |
| Penumbra, INC. | $15.66 | 2022 | |
| Angiodynamics, INC. | $15.55 | 2023 | Bioflo |
| Regeneron Healthcare Solutions, INC. | $14.11 | 2019 | |
| Baylis Medical Technologies INC. | $12.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zia Rab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.